The read at a glance
Computed from the FY2025 annual filing. Full history and the components behind each score are in the app.
- Distress risk · Altman Z-Score 6.15 — safe zoneOK
- Earnings-manipulation signal · Beneish M -3.46 — no flag raisedOK
- Earnings quality 79/100 — accruals in line with cashOK
Where the revenue comes from
Fiscal 2025, as CASTLE BIOSCIENCES INC reports it. History and quarterly detail are in the app.
- Dermatologic$216.4M
- Non Dermatologic$127.9M
Leadership changes
From CASTLE BIOSCIENCES INC's own filings, the day they're filed.
- Rodney Cotton · director · appointmenteff. 2024-03-26
- Mara G. Aspinall · Directors · departureeff. 2024-03-26
- Good Reason · departure
Latest filings
- 8-K · Company announcement2026-05-29
- 10-Q · Quarterly report2026-05-06
- 8-K · Company announcement2026-05-06
- DEF 14A · Annual proxy (pay & governance)2026-04-08
- 10-K · Annual report2026-02-26
In the full recordFree for 14 days
- The filings, readable — with what changed vs the prior year highlighted🔒
- Full financial statements, industry-aware, every figure source-linked🔒
- Forensic score history & components — the trend, not one year🔒
- Ownership: insider buys/sells, clusters, activist stakes🔒
- Ana — ask anything about CASTLE BIOSCIENCES INC, every answer cited🔒
- The Intelligence Brief — added when CASTLE BIOSCIENCES INC's brief passes our SEC-figure check🔒
Every figure links to the filing it came from, and analysis whose figures don't match SEC data is rejected before publication.
14-day free trial, no credit card. For research purposes only; not investment advice.